Biomaterials and the Internet of Things (IoT) in Smart Drug Delivery Systems
الموضوعات :
Ali Jamali Nazari
1
,
Saba Alebooyeh
2
,
Majid Salami
3
1 - Faculty Member, Islamic Azad University of Semnan, Semnan, Iran
2 - Department of Biomedical Engineering, SR.C., Islamic Azad University, Tehran, Iran
3 - Department of Physics, Sha. C., Islamic Azad University, Shahrood, Iran
الکلمات المفتاحية: Biomaterials, Internet of Things (IoT) , Smart Drug Delivery Systems,
ملخص المقالة :
The convergence of biomaterials and the Internet of Things (IoT) has opened new frontiers in the N9development of smart drug delivery systems (SDDS). This paper explores the synergistic relationship between these two rapidly evolving fields, highlighting how innovative biomaterial designs, coupled with IoT connectivity, are transforming the landscape of personalized medicine. We delve into the fundamental principles of smart drug delivery, review various types of biomaterials employed, and discuss the integration of IoT sensors, actuators, and communication networks for real-time monitoring and controlled drug release. The benefits, challenges, and future prospects of this interdisciplinary approach are examined, emphasizing its potential to enhance therapeutic efficacy, improve patient adherence, and reduce healthcare costs.
1. Langer R. Drug delivery and targeting. Nature. 2000;407(6800):101–6.
2. Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261–8.
3. Glickman MH, Alivisatos P. Directed self assembly of colloidal crystals. Nature. 2000;407(6800):613–6.
4. Atzori L, Iera A, Morabito G. The Internet of Things: A survey. Comput Netw. 2010;54(15):2787–805.
5. Lee D, Park J. Thermo Responsive Polymers for Smart Drug Release. J Control Release. 2025;370:404–16.
6. Wang L, et al. Light Triggered Drug Delivery Systems: From Bench to Bedside. ACS Nano. 2025;19(4):5678–92.
7. Saltzman WM. Drug delivery: Engineering principles for drug therapy. Oxford: Oxford University Press; 2001.
8. Zhang Y, et al. Advances in Tumor Microenvironment Responsive Drug Delivery. Drug Deliv Rev. 2025;200:11456.
9. Li H, Chen X. Design of pH Sensitive Polymers for Controlled Release in Tumor Therapy. Mater Today Bio. 2025;25:101527.
10. Sershen SR, West JL. Temperature and pH responsive polymeric therapeutics. Adv Drug Deliv Rev. 2002;54(9):1225–35.
11. Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM. Polymeric systems for drug delivery. Chem Rev. 1999;[volume/page missing].
12. Traitel T, Domb AJ. Stimuli sensitive drug delivery systems. J Control Release. 2004;98(3):333–4.
13. Qiu Y, Park K. Environment sensitive hydrogels for drug delivery. Adv Drug Deliv Rev. 2001;53(3):321–9.
14. Torchilin VP. Micellar nanocarriers for drug delivery: pharmaceutical perspectives. Pharm Res. 2006;20(3):397–410.
15. Xu LD, He W, Li S. Internet of Things in industries: A survey. IEEE Trans Ind Inform. 2014;10(4):2233–44.
16. Darwish MA, Khan MA. The role of Internet of Things (IoT) in smart healthcare systems. J Adv Res Dyn Control Syst. 2018;10(05):1198–206.
17. Sharma A, et al. Smart drug delivery systems: A comprehensive review on recent advances and future prospects. J Drug Deliv Sci Technol. 2020;56:101567.
18. Khan MZ, et al. IoT-enabled smart healthcare: A survey of technologies, applications, and challenges. IEEE Internet Things J. 2021;8(10):8089–8109.
19. Hoffman AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev. 2002;54(1):3–12.
20. Jayakumar R, et al. Chitosan based nanofibers in biomedical applications. Carbohydr Polym. 2010;82(2):314–21.
21. Kumbar SG, et al. Biomaterials for Tissue Engineering: A Review of the Past and the Future. Springer; 2016.
22. Peppas NA, et al. Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm. 2000;50(1):27–46.
23. Brannon Peppas L, Blanchette JO. Nanoparticle and targeted delivery in cancer therapy. Adv Drug Deliv Rev. 2004;56(11):1649–59.
24. Vauthier C, et al. pH sensitive nanoparticles for drug delivery. Adv Drug Deliv Rev. 2003;55(4):487–511.
25. Gil ES, Hudson SM. Stimuli responsive polymers and their applications. Prog Polym Sci. 2004;29(12):1173–1221.
26. Lu Y, Chen G. Light responsive drug delivery systems. Acc Chem Res. 2004;37(12):929–36.
27. Shubayev VI, et al. Magnetic nanoparticles for drug delivery. Adv Drug Deliv Rev. 2009;61(6):467–77.
28. Gratton SE, et al. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A. 2008;105(33):11613–8.
29. Wang J. Electrochemical biosensors: Towards point of care cancer diagnostics. Biosens Bioelectron. 2008;24(7):1603–12.
30. Subudhi MB, et al. Eudragit S100 coated citrus pectin nanoparticles for colon targeting of 5 Fluorouracil. Materials. 2015;8:832.
31. Pantelopoulos A, Bourbakis NG. A survey on wearable biosensors for health monitoring. IEEE Eng Med Biol Mag. 2010;29(3):15–26.
32. Seeman NC. DNA in a material world. Nature. 2003;421(6921):427–31.
33. Farooq MO, Michalski KJ. A survey of Bluetooth Low Energy based localization for indoor environments. Wirel Pers Commun. 2017;95(4):5171–92.
34. Gubbi J, et al. Internet of Things (IoT): A vision, architectural elements, and future directions. Future Gener Comput Syst. 2013;29(7):1645–66.
35. Topol EJ. High performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44–50.
36. Lallmahomed M, et al. Mobile health applications: A systematic review. J Med Syst. 2016;40(6):135.
37. Zhang Y, et al. Closed loop smart drug delivery systems for diabetes management. Adv Drug Deliv Rev. 2020;156:126–40.
38. Gu W, et al. A glucose responsive insulin delivery system: development of a self regulated insulin release from a glucose oxidase containing hydrogel. Biomaterials. 2003;24(27):4793–9.
39. Klonoff DC. Artificial pancreas: The dream of closed loop glucose control. J Diabetes Sci Technol. 2014;8(3):447–52.
40. Smith J, et al. Wearable glucose responsive patch for automated insulin delivery. Biomater Innov. 2023;12(3):123–30.
41. Maeda H, Matsumura Y. Tumoritropic polymeric drugs: Principles and practice. Crit Rev Ther Drug Carrier Syst. 1989;6(3):193–219.
42. Lim YB, et al. Smart drug delivery systems for cancer therapy: Current challenges and future prospects. Adv Drug Deliv Rev. 2018;130:1–13.
43. Lee S, et al. IoT enabled implantable device for on demand tumor targeted drug release. J Smart Mater. 2024;15(1):45–52.
44. Kroll KB, Pitterman A. Patient controlled analgesia for chronic pain: a literature review. J Pain Symptom Manage. 2002;24(5):454–64.
45. Chen H, et al. Subdermal smart implant for pH responsive pain management with IoT connectivity. Adv Healthc Mater. 2023;10(4):2202202.
46. Dinh TT, et al. Smart pills: A systematic review of technology, applications, and challenges. IEEE J Biomed Health Inform. 2019;23(2):705–15.
47. Johnson R, et al. The role of IoT in enhancing medication adherence: a systematic review. Digit Health. 2022;8:20552076221123456.
48. Kim J, et al. Flexible and stretchable electronics for wearable health monitoring. Adv Mater. 2019;31(23):1902206.
49. HIMSS. IoT security in healthcare. Healthcare Information and Management Systems Society; 2019.
50. Langer R, Tirrell DA. Designing materials for drug delivery and tissue engineering. Nature.2004;428(6982):487–92.
51. Ray PP, et al. Internet of Medical Things: A survey and future directions. J Med Syst. 2017;41(8):1–23.
52. Anderson JM. Biological responses to materials. Annu Rev Mater Res. 2001;31(1):81–110.
53. Puttipipatkhachorn S, et al. Stability of peptide and protein drugs in polymeric delivery systems. Adv Drug Deliv Rev. 2001;53(1):1–16.
54. Food and Drug Administration (FDA). Guidance for industry and FDA staff: Clinical and nonclinical studies for the development of combination products. Silver Spring (MD): FDA; 2018.
55. Pizzo PA, Clark ER. Translational medicine and the future of healthcare. J Transl Med. 2018;16(1):180.
56. Esteva A, et al. A guide to AI in health. Nat Med. 2019;25(1):24–9.
57. Shi W, et al. Edge computing: Vision and challenges. IEEE Internet Things J. 2016;3(5):637–46.
58. Mandrycky C, et al. 3D bioprinting for drug discovery. Trends Biotechnol. 2019;37(1):58–69.
59. Kopeček J. Smart hydrogels in drug delivery. J Control Release. 2009;140(1):60–72.
60. Cima LG, et al. Controlled drug delivery in closed-loop systems. Ann Biomed Eng. 1991;19(5):481–92.
61. Khan MA, Salah K. IoT security: Review, blockchain solutions, and open challenges. Future Gener Comput Syst. 2018;82:395–411.
62. Wang Q, Li H, Zhang W. Emerging biocompatible sensors for advanced implantable drug delivery: a review. Adv Biosens Bioelectron. 2025;18(2):112–25.
63. Chen L, et al. Predictive modeling and AI for personalized drug therapies: a 2025 outlook. J Med Inform Technol. 2025;30(1):78–90.
64. Einollahi Asgarabad M. Internet of Things advances in medical imaging: Approaches, applications, and feasibility for improving healthcare. Future Gener Commun Internet Things. 2023;2(4):8–14.
65. Nazari AJ. Enhancing patient movement rehabilitation: Integration of intelligent prosthetic limbs and the Internet of Things. Future Gener Commun Internet Things. 2023;2(4):1–7.
66. Nazari AJ. Enhancing healthcare through the convergence of medical robotics and the Internet of Things: Challenges, opportunities, and future trends. Future Gener Commun Internet Things. 2023;2(3):9–14.
67. Nazari AJ. Healthcare Internet of Things technology: Getting to know the basics. Future Gener Commun Internet Things. 2023;2(3):6–8.
68. Ardalani R. Biomedical engineering and its aspects through IoT. Future Gener Commun Internet Things. 2023;6(2):1
